STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #360 by analyst upside · 2026-06-27
WVE
Wave Life Sciences Ltd.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+276.3%
implied upside to consensus target
Current Price $5.83
Consensus Target $21.94
Bull Target $43.0
Bear Target $12.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
14
Hold
0
Sell
0
52-Week Low $5.02
52-Week High $21.73
YTD Return -63.4%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E -5.4x
EPS (TTM) $-1.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $72M
Profit Margin -255.7%
52-WEEK RANGE
52-Week Low $5.02
52-Week High $21.73
Current Price $5.83
Bear Target $12.0
Bull Target $43.0
● Now $5.83 ● Target $21.94
TRADING DATA
Avg Volume 4.1M
YTD Return -63.4%
Analyst Count 16
Consensus Buy
Upside to Target +276.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Wave Life Sciences Ltd. (WVE) is currently trading at $5.83 with a Wall Street consensus price target of $21.94, implying potential upside of 276.3% over the next 12 months. 16 analysts currently cover WVE, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $43.0, while the most cautious has a target of $12.0.

WVE operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 63.4% year-to-date and is currently trading near the lower end of its 52-week range of $5.02 – $21.73.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for WVE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wells Fargo — Reiterated
Overweight → Overweight 2026-05-20 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-05-19 31% win rate (48 calls)
Citigroup — Reiterated
Buy → Buy 2026-05-04 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-04-30 Building track record
Truist Securities — Reiterated
Buy → Buy 2026-04-29 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-04-14 31% win rate (48 calls)
B of A Securities — Reiterated
Buy → Buy 2026-03-27 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-03-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
49
out of 100
Coverage depth
22/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →